Leggett & Platt stock soars after Somnigroup proposes acquisition

Somnigroup International proposed an all-stock acquisition of Leggett & Platt, offering Leggett shareholders Somnigroup common stock valued at $12.00 per share — a 30.3% premium to Leggett’s 30-day average — sending LEG shares up about 8% to $11.06. Under the proposal Leggett would operate independently within Somnigroup’s portfolio, Somnigroup says the deal is accretive before synergies and tax-advantaged for Leggett holders; the company has requested a board response by Dec. 22 and the transaction remains subject to regulatory and customary closing conditions (not requiring Somnigroup shareholder approval).

Analysis

Winners are Leggett & Platt (LEG) shareholders who see a near-term 30.3% premium implied by Somnigroup’s (SGI) $12-per-share all-stock proposal; SGI can benefit long-term from vertical consolidation but risks dilution if it issues stock to fund the deal. Competitors in mattress retail (e.g., Mattress Firm, Tempur Sealy peers) may face increased pricing power from a larger combined platform, while standalone suppliers to bedding channels could lose volumes if LEG’s independent commercial relationships are repriced.

Immediate market impact: expect elevated LEG share volatility into the Dec 22 board deadline and potential IV spikes in LEG options; bond markets are unlikely to react materially unless SGI finances via high-yield debt (watch SGI credit spreads widen >50bps). Tail risks include regulator or antitrust scrutiny, SGI equity dilution, or LEG board rejection; low-probability takeover auctions or a higher bidder would rapidly rerate values in days.

Trade implications: short-term (days–weeks) event trade around Dec 22 favors directionally long LEG or call spreads, hedged with puts or a calibrated short SGI position to neutralize market beta; medium-term (months) reassess on deal progress and synergy disclosure. Sector rotation: increase exposure to consumer-discretionary retail consolidation beneficiaries (+1–3% tactical overweight) and trim cyclicals dependent on independent component sales to bedding if LEG’s external revenues are curtailed.

Contrarian view: the market may underprice negotiation risk—$12 is a headline valuation, not a done deal; LEG’s post-deal free-float could be reduced and liquidity impaired, leaving a multi-week unwind risk if the board drags. Historical parallels (supply-chain-driven roll-ups) show initial pop then 10–20% mean reversion absent clear synergy plans; thus capitalize on the premium but protect against deal failure with defined hedges and exit triggers.

Key Decisions for Investors

• Establish a tactical long in LEG equal to 2–3% of portfolio at or below $11.50 (average target entry $11.00–$11.50); trim to lock gains at $12.00 (near-term deal price) and place a protective stop at $9.50 to cap downside (~‑14%).
• Buy a defined-risk call spread on LEG: Jan 2026 $11/$13 call spread, size 0.5–1.0% portfolio, to capture upside through post-board vote while limiting premium outlay; simultaneously buy a small LEG Jan 2026 $9–10 put (size 0.25–0.5%) as catastrophe protection if deal fails.
• Initiate a small asymmetric pair: long LEG (as above) and short 0.5% SGI outright or buy SGI Jan 2026 downside protection (puts) if SGI rallies >10% pre-close; reason: potential dilution/earnings dilution risk to SGI and mispricing of accretion claims.
• If Leggett’s board rejects the offer or a competing bidder emerges by Dec 22, increase long LEG exposure to 3–4% only after the new bid is firmed (>5% premium over $12) or if Somnigroup announces committed financing; otherwise unwind to pre-defined targets within 5 trading days of the catalyst.